21 studies found for:    " August 01, 2007":" August 31, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
2 Completed
Has Results
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Condition: Human Immunodeficiency Virus - Type 1
Interventions: Drug: Darunavir (DRV);   Drug: Ritonavir (rtv)
3 Completed Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
Condition: HIV Infections
Interventions: Other: Behavioral counseling;   Device: HIV-1 Antibody Test Kit
4 Completed Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Condition: HIV Infections
Intervention: Procedure: Infant feeding counseling that includes Flash-heat
5 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
6 Unknown  Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
7 Unknown  Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
Conditions: HIV Infections;   Cancer, Second Primary
Interventions: Dietary Supplement: Probiotic Yogurt B: with various micronutrients;   Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients;   Dietary Supplement: Probiotic yogurt C: with basic micronutrients;   Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients
8 Terminated A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: efavirenz or nevirapine
9 Completed Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
Condition: HIV Infections
Intervention:
10 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
11 Completed Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Condition: HIV Infections
Interventions: Drug: matching placebo;   Drug: Bevirimat
12 Completed Autologous Dendritic Cell Vaccine in HIV1 Infection
Condition: HIV Infections
Intervention: Biological: Autologous HIV-1 ApB DC Vaccine
13 Completed DDI HV (ATV - Merck)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Drug: Atazanavir + Raltegravir
14 Completed Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
Condition: HIV Infections
Intervention: Drug: Pyridostigmine tablets
15 Completed
Has Results
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518);   Drug: Placebo
16 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
17 Completed
Has Results
RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir
18 Terminated
Has Results
Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
19 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
20 Unknown  Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neurotoxicity;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years